loader2
Partner With Us NRI

Kilitch Drugs (India) Ltd share Price Today

Company details

370.15
400.00
138.00
470.00
6M Return 56.81%
1Y Return 166.55%
Mkt Cap.(Cr) 625.43
Volume 17,345
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 17,345

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Kilitch Drugs (India) Ltd shares SWOT Analysis

Strengths (9)

  • Company with high TTM EPS Growth
  • Effectively using its capital to generate profit - RoCE improving in last 2 years
  • Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Weakness (1)

  • Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Opportunity (2)

  • Highest Recovery from 52 Week Low
  • RSI indicating price strength

Threats (2)

  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 402.6
R2 416.2
R3 432.4
Pivot

386.35

S1 372.7
S2 356.5
S3 342.9
EMA SMA
374.2
379.6
360.2
314.2
366.3
396.3
372.9
294.0
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
BP FINTRADE PRIVATE LIMITED Bulk Purchase 2018-03-06 96.36 78214 NSE
SHAH DIPAK KANAYALAL Bulk Sell 2018-03-06 96.35 66699 NSE
BP FINTRADE PRIVATE LIMITED Bulk Sell 2018-03-06 98.98 56811 NSE
Name Category Shares
Bhavin Mukund Mehta PROMOTER 20.92%
Mukund Mehta PROMOTER 7.09%
Kilitch Company (Pharma) Limited PROMOTER 41.22%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Kilitch Drugs (India) Ltd Stocks COMPARISON

Financials( in Cr) Kilitch Drugs (India) Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Zydus Lifesciences Ltd
Price 388.90 1,620.55 1,496.95 6,157.90 1,007.35
% Change -0.18 1.02 2.30 1.88 0.77
Mcap Cr 625.43 388,824.23 120,856.26 102,719.31 101,964.37
Revenue TTM Cr 139.60 43,885.68 15,790.60 24,669.70 17,237.40
Net Profit TTM Cr 8.28 8,560.84 2,513.47 4,507.30 1,997.30
PE TTM 43.07 41.13 29.93 19.30 30.34
1 Year Return 166.55 64.78 68.33 37.28 109.04
ROCE 10.24 16.79 14.76 25.99 16.25
ROE 5.70 16.46 10.66 21.21 14.05
INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 146.59 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 30,755.54 31,723.05
LAST 3M 69,913.40 26,515.65
LAST 6M 130,081.93 60,306.69
LAST 12M 189,259.39 205,003.99
Kilitch Drugs (India) Limited - Trading Window

Mar 26, 2024 l NSE Announcement

Kilitch Drugs (India) Limited - Updates

Mar 22, 2024 l NSE Announcement

Kilitch Drugs (India) Limited - Loss of Share Certificates

Mar 21, 2024 l NSE Announcement

Date Action Type Ratio
No data found

Kilitch Drugs (India) Ltd Information

Stock PE (TTM)
43.07
Promoter Holding
69.23%
Book Value
104.1027
ROCE
10.24%
ROE
5.7%
Description
  • Kilitch Drugs (India) Limited (KDIL) was incorporated in May, 1992 as a public limited company. The Company is a pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia. Its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms of creating safe pharmaceutical solutions. The Company went public in Feb.`94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules,liquid orals, ointments, creams and injectables. Even before the plant was commissioned, the company came out with a rights issue in Oct.`95 to expand the injectible capacity. Commercial production at the plant at Thane commenced in 1996. The company has two divisions - O T C and ethical. A Pharmaceutical formulation plant at Sana`a Republic of Yemen was set up at a cost of Rs 15 crore by entering into an agreement with Al-Fath Trading Corporation.It also entered into an agreement with a Miami company for the export of their medicine to West Indies, south and central America. The company entered into a contract with one of the leading company in the Republic of Yemen which it had set up at a cost of Rs 2.5-cr tanning unit, which was implemented in the year 1995-96. The company had set up a bulk drug unit at Patalganga, Maharashtra for producing raw materials for formulations. The company exports to Sudan, Yemen, middle-east, Miami and certain south American companies. KDIL started marketing a range of injectables from the factory on ethical basis. The company also introduced a new product clue-plus, Bon-Bon Gripe Water and Kilitch Balm. The Company launched a new product `BENIN` in the market in 2011. During the year 2011-12, the Company sold its business located at Paonta Sahib, Himachal Pradesh as a going concern on a slump sale basis along with transfer of services set forth in the Business Transfer Agreement (BTA). The undertaking was sold and transferred on 28th February 2012 after getting all the necessary clearances as indicated in the BTA. It retained its Name, Trademark (Kilitch) and all other properties and assets at Mumbai. It transferred certain products by entering into a Product Transfer Agreement (PTA) with Akorn India Pvt. Ltd. (AIPL) by which the right to manufacture certain products by the Company at Mumbai were sold to AIPL.

Registered Address

C-301/2 MIDC TTC Indl Area, Pawane Village, Thane, Maharashtra, 400705

Tel : 91-022-27670322/27680913/65144185
Email : info:kilitch.com
Website : http://www.kilitch.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524500
NSE Code : KILITCH
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE729D01010

FAQ’s on Kilitch Drugs (India) Ltd Shares

You can buy Kilitch Drugs (India) Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Kilitch Drugs (India) Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Mar 28, 2024 03:55 PM the closing price of Kilitch Drugs (India) Ltd was ₹ 388.90.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Mar 28, 2024 03:55 PM, the market cap of Kilitch Drugs (India) Ltd stood at ₹ 625.43.

The latest PE ratio of Kilitch Drugs (India) Ltd as of Mar 28, 2024 03:55 PM is 43.07

The latest PB ratio of Kilitch Drugs (India) Ltd as of Mar 28, 2024 03:55 PM is 0.27

The 52-week high of Kilitch Drugs (India) Ltd share price is ₹ 470.00 while the 52-week low is ₹ 138.00

Download Our

Download App
market app